GlassScriptPhysician profile
Jayant P Agarwal
NPI 1508878372
$33,358.04
in general payments reported to CMS, 2019-2025
22 companies · $1,195 in 2025
The $1,195 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,870 · 2021: $31.14 · 2022: $6,477 · 2023: $6,000 · 2024: $14K · 2025: $1,195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $2,750 · Food and Beverage: $2,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,770.00 |
| Travel and Lodging | $2,750.25 |
| Food and Beverage | $2,459.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $28,607.23 | 2019-2024 | Djo Surgical |
| Integra Lifesciences Corporation | $2,012.34 | 2024-2025 | Codman Certas, Surgimend, Integra |
| Mentor Worldwide LLC | $665.12 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $326.75 | 2024-2025 | |
| Stryker Corporation | $316.92 | 2019-2024 | Na, Variax |
| Davol INC. | $306.03 | 2022-2024 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $279.64 | 2025 | |
| Becton, Dickinson and Company | $163.33 | 2025 | Phasix Mesh |
| Motiva USA, LLC | $125.00 | 2025 | |
| Innovation Technologies INC | $124.40 | 2022 | |
| Sientra, INC. | $115.67 | 2019 | |
| Allergan, INC. | $99.61 | 2019 | |
| Tela Bio, INC. | $88.33 | 2024 | Ovitex 2s |
| Janssen Biotech, INC. | $41.52 | 2024 | Tremfya |
| Vioptix INC | $31.14 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.72 | 2024 | |
| Polynovo North America LLC | $18.86 | 2025 | Novosorb Btm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.43 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayant Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.